BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5812585)

  • 21. A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study.
    Modesitt SC; Sill M; Hoffman JS; Bender DP;
    Gynecol Oncol; 2008 May; 109(2):182-6. PubMed ID: 18295319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Carcinogenic effects of anti neoplastic and immunosuppressive drugs].
    Brock N; Schneider B
    Arzneimittelforschung; 1971 Apr; 21(4):435-43. PubMed ID: 5108136
    [No Abstract]   [Full Text] [Related]  

  • 23. Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer.
    Stolinsky DC; Bogdon DL; Solomon J; Bateman JR
    Cancer; 1972 Sep; 30(3):654-9. PubMed ID: 5075351
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drug induced hematological disorders].
    Kohashi S; Okamoto S
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():74-7. PubMed ID: 23156489
    [No Abstract]   [Full Text] [Related]  

  • 25. Initial clinical trials with methyl-CCNU 1-(2-chlorethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (MeCCNU).
    Young RC; Walker MD; Canellos GP; Schein PS; Chabner BA; DeVita VT
    Cancer; 1973 May; 31(5):1164-9. PubMed ID: 4705154
    [No Abstract]   [Full Text] [Related]  

  • 26. Combination of bleomycin and mitomycin after failure of cisplatin and alkylating agent therapy in epithelial ovarian cancer.
    Lawton FG; Perren TJ; Luesley DM; Meanwell CA; Chan KK; Mould JJ; Blackledge G
    Cancer Treat Rep; 1986 Apr; 70(4):525-6. PubMed ID: 2421894
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chemotherapy of solid tumors. Epitheliomas and sarcomas of non-hematopoietic organs].
    Clavel B
    Sem Hop; 1971 May; 47(22):1439-48. PubMed ID: 4326096
    [No Abstract]   [Full Text] [Related]  

  • 28. Aminoglutethimide-induced hematologic toxicity: worldwide experience.
    Messeih AA; Lipton A; Santen RJ; Harvey HA; Boucher AE; Murray R; Ragaz J; Buzdar AU; Nagel GA; Henderson IC
    Cancer Treat Rep; 1985 Sep; 69(9):1003-4. PubMed ID: 4028032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous low-dose cyclophosphamide (NSC-26271) therapy in advanced ovarian cancer.
    Mangioni C; Bolis G; Natale N; Morasca L
    Eur J Cancer (1965); 1976 May; 12(5):353-6. PubMed ID: 954793
    [No Abstract]   [Full Text] [Related]  

  • 30. Carbamazepine and hematological monitoring.
    Hart RG; Easton JD
    Ann Neurol; 1982 Mar; 11(3):309-12. PubMed ID: 7092183
    [No Abstract]   [Full Text] [Related]  

  • 31. [Studies on the hematologic tolerance of Bactrim].
    Maier C; Heer HR
    Schweiz Med Wochenschr; 1972 Jul; 102(26):923-6. PubMed ID: 5034540
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase II trial of hexamethylmelamine in ovarian carcinoma resistant to alkylating agents.
    Bonomi PD; Mladineo J; Morrin B; Wilbanks G; Slayton RE
    Cancer Treat Rep; 1979 Jan; 63(1):137-8. PubMed ID: 105805
    [No Abstract]   [Full Text] [Related]  

  • 33. The clinical pharmacology of hexamethylmelamine: Phase I study.
    Louis J; Louis NB; Linman JW; Donnelly WJ; Isaacs BL; Schwartz SO
    Clin Pharmacol Ther; 1967; 8(1):55-64. PubMed ID: 4959523
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug-induced immune cytopenia.
    Garratty G
    Transfus Med Rev; 1993 Oct; 7(4):213-4. PubMed ID: 8241610
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical trial of the oral form of a new podophyllotoxin derivative, VP-16-213 (NSC-141540), in patients with advanced neoplastic disease.
    Nissen NI; Hansen HH; Pedersen H; Stroyer I; Dombernowsky P; Hessellund M
    Cancer Chemother Rep; 1975; 59(5):1027-9. PubMed ID: 1106845
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hematologic disorders in acute alcoholism. Study of 27 chronic alcoholic patients hospitalized in a state of intoxication].
    Coste T; Gouffier E; Paraf A
    Sem Hop; 1972 Sep; 48(37):2427-32. PubMed ID: 4346778
    [No Abstract]   [Full Text] [Related]  

  • 37. [Blood damage from alcohol].
    Bottiger LE
    Lakartidningen; 1976 Nov; 73(47):4099-101. PubMed ID: 994602
    [No Abstract]   [Full Text] [Related]  

  • 38. Hexamethylmelamine. An evaluation of its role in the therapy of cancer.
    Legha SS; Slavik M; Carter SK
    Cancer; 1976 Jul; 38(1):27-35. PubMed ID: 820422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II trial of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) combination chemotherapy in advanced ovarian carcinoma.
    Kane R; Harvey H; Andrews T; Bernath A; Curry S; Dixon R; Gottlieb R; Kukrika M; Lipton A; Mortel R; Ricci J; White D
    Cancer Treat Rep; 1979 Feb; 63(2):307-9. PubMed ID: 109201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute and subacute toxicity of apholate to the chick and Japanese quail.
    Sherman M; Herrick RB
    Toxicol Appl Pharmacol; 1966 Sep; 9(2):279-92. PubMed ID: 5969416
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.